1. Home
  2. NRXP vs SGRP Comparison

NRXP vs SGRP Comparison

Compare NRXP & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SGRP
  • Stock Information
  • Founded
  • NRXP 2015
  • SGRP 1967
  • Country
  • NRXP United States
  • SGRP United States
  • Employees
  • NRXP N/A
  • SGRP N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SGRP Business Services
  • Sector
  • NRXP Health Care
  • SGRP Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • SGRP Nasdaq
  • Market Cap
  • NRXP 32.6M
  • SGRP 27.8M
  • IPO Year
  • NRXP N/A
  • SGRP 1996
  • Fundamental
  • Price
  • NRXP $2.05
  • SGRP $1.05
  • Analyst Decision
  • NRXP Strong Buy
  • SGRP
  • Analyst Count
  • NRXP 4
  • SGRP 0
  • Target Price
  • NRXP $28.50
  • SGRP N/A
  • AVG Volume (30 Days)
  • NRXP 105.1K
  • SGRP 40.8K
  • Earning Date
  • NRXP 05-20-2025
  • SGRP 05-20-2025
  • Dividend Yield
  • NRXP N/A
  • SGRP N/A
  • EPS Growth
  • NRXP N/A
  • SGRP N/A
  • EPS
  • NRXP N/A
  • SGRP 0.50
  • Revenue
  • NRXP N/A
  • SGRP $228,869,000.00
  • Revenue This Year
  • NRXP N/A
  • SGRP N/A
  • Revenue Next Year
  • NRXP N/A
  • SGRP N/A
  • P/E Ratio
  • NRXP N/A
  • SGRP $2.10
  • Revenue Growth
  • NRXP N/A
  • SGRP N/A
  • 52 Week Low
  • NRXP $1.10
  • SGRP $1.00
  • 52 Week High
  • NRXP $6.01
  • SGRP $3.12
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 51.65
  • SGRP 31.33
  • Support Level
  • NRXP $1.97
  • SGRP $1.00
  • Resistance Level
  • NRXP $2.14
  • SGRP $1.15
  • Average True Range (ATR)
  • NRXP 0.11
  • SGRP 0.06
  • MACD
  • NRXP 0.01
  • SGRP 0.01
  • Stochastic Oscillator
  • NRXP 68.97
  • SGRP 25.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SGRP SPAR Group Inc.

SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.

Share on Social Networks: